Crowdonomics
All companies
Lambs logo

Lambs

Operating

Faraday Labs Inc

Healthcare · Santa Monica, CA · Founded 2018

Apparel that boosts your immune health, cognition, recovery, and sleep

Valuation cap ⓘ
$30.0M
As of Mar 2023 · from Reg CF Offering (2022) · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$4,900,514
Crowd $623K · Private $4.3M · 4 rounds since 2019
Latest share price
$0.4851
Section 4(a)(2) · Convertible Note · Apr 2019 disclosed sale

Financials

FY2020–FY2024 · from SEC filings · hover any figure for its source
$2.9M
−$993K
2020
$2.9M
−$1.2M
2021
$2.5M
−$1.2M
2022
$2.9M
−$514K
2023
$3.9M
−$317K
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020 reviewed
FY2021 reviewed
FY2022
FY2023 reviewed
FY2024 reviewed
Income statement
Revenue
$2,869,831
$2,908,972
$2,497,210
$2,900,756
$3,883,184
Cost of goods sold
$1,504,782
$1,417,168
$1,302,660
$1,179,774
$1,459,330
Gross margin
48%
51%
48%
59%
62%
Net income
-$992,659
-$1,224,263
-$1,165,676
-$513,653
-$317,032
Taxes paid
$2,802
$0
$0
$0
$0
Balance sheet
Cash
$193,245
$297,157
$307,803
$700,831
$1,447,323
Accounts receivable
$89
$253
$0
$0
-$134
Total assets
$560,132
$747,166
$734,021
$1,332,728
$2,020,666
Short-term debt
$474,251
$654,462
$162,337
$1,729,379
$112,287
Long-term debt
$0
$0
$694,291
$2,683,768
$0
Total liabilities
$474,251
$654,462
$856,628
$4,413,147
$112,287
Other
Headcount
—
5
4
5
6

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Valuation caps on SAFE / convertible note rounds
$30.0M
Valuation cap
Reg CF · SAFE · Jun 2022

Dashed amber bars are a SAFE or convertible note's valuation cap — the most it converts at, not what the company is worth.

Share price over rounds

log scale
$0.4851$0.0589$0.0071
Apr 2019Mar 2020
Round offering price or verified disclosed saleDisclosed sale, unverified or year-only

Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.

Cap table

Principal holders% as the filing states it, Jun 17, 2025

  • Arthur Menard37.2%of company
  • Science Ventures Fund II, LP22.6%of company

Sold to the crowd

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Reg CF · SAFE · Nov 2024Closedvia WeFunder
Raised $0 / $618K
Reg CF · SAFE · Jun 2022Closedvia Republic
Raised $622.9K / $1.1MInvestors 982Valuation cap $30M

Team

2 people
Arthur Menard
CEO
Thomas Calichiama
COO

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not required3+ reports filed & assets ≤ $10M

Filed 3 of 4 annual reports (FY2022–FY2025)

982 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-ARJun 17, 20250001920988-25-000002
    EDGAR
  • Form C/AApr 30, 20250001670254-25-000514
    EDGAR
  • Form C/ADec 17, 20240001670254-24-001174
    EDGAR
  • Form CNov 14, 20240001670254-24-001083
    EDGAR
  • Form C-ARSep 24, 20240001920988-24-000001
    EDGAR
  • Form C-ARMay 1, 20230001738026-23-000004
    EDGAR
  • Form C-UMar 28, 20230001920988-23-000001
    EDGAR
  • Form CMay 20, 20220001920988-22-000001
    EDGAR
Source: ManualCIK 0001920988DE

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.